A landmark study reveals a surprising driver of successful retirement saving via 401(k).
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results